Inflatable implants conceal more naturally and were favored for patient and partner satisfaction in a 2024 meta-analysis. Malleable rods have no pump, fail mechanically less often and suit limited hand function. Infection rates did not differ significantly. The better choice depends on dexterity, pelvic history, Peyronie’s disease, budget and priorities.
Both devices are placed inside the corpora cavernosa, within the tunica albuginea, and both are intended for men with erectile dysfunction that has not responded to, or is not suited to, less invasive treatment. They differ in how they produce and release rigidity, and that difference drives almost every trade-off below. This page compares the two designs using pooled analyses and reviews that were read for this article, and it states plainly where the numbers are thin, heterogeneous or unavailable. For the surgical detail of each operation, see the procedure pages on inflatable penile prosthesis implantation and malleable penile prosthesis implantation.
Side-by-side comparison
| Feature | Three-piece inflatable | Malleable (semi-rigid) |
|---|---|---|
| Mechanism | Two cylinders within the corpora cavernosa, a scrotal pump and an abdominal fluid reservoir. Fluid is moved into the cylinders for rigidity and returned to the reservoir to deflate.[1] | A pair of semi-rigid rods within the corpora cavernosa. There is no fluid, pump or reservoir; the penis stays semi-rigid and the rods are bent upward for intercourse.[1] |
| Concealment and flaccid / erect result | Deflates for a flaccid state. After any prosthesis, perceived shortening is the most frequent complaint, and reduced glans engorgement may contribute.[1] A European position statement rates inflatable devices superior for rigidity, girth and concealability (expert-opinion level, written in the Peyronie’s context).[5] | Always semi-rigid; the device is positioned for concealment outside sexual activity, and newer designs are described as offering dependable concealment.[1] The same position statement rates semirigid devices behind inflatables on these measures.[5] |
| Dexterity needs | Requires locating and compressing the scrotal pump. One review cites roughly 10–14 pump compressions for three-piece devices versus 3–6 for two-piece devices.[1] | No pump. Rods may be preferable for men with poor manual dexterity.[3] |
| Mechanical failure and revision | Meta-analysis of five studies: mechanical failure significantly higher than with malleable devices (odds ratio 5.60; 95% CI 2.02–15.53).[2] Reported dysfunction ranges from 1.6% to 25% across series, with 10-year survival figures of 68.5%–78.2% in studies cited by a 2024 review.[1] | Associated with lower malfunction and revision risk,[3] but not zero: reported dysfunction ranges from 0.5% to 12%, with survival of 83%–84% in two long-term series (about 5 and about 12 years).[1] |
| Infection risk | 0.6%–3.5% in primary three-piece series cited by a 2024 review.[1] No significant difference from malleable devices in the meta-analysis.[2] | 1.4%–8.3% in series cited by the same review.[1] No significant difference from inflatable devices in the meta-analysis.[2] |
| Erosion | 0.3%–2% in cited three-piece series.[1] | 1.4%–5.1% in cited series; the review concludes erosion was higher with malleable devices, although the ranges overlap.[1] |
| Satisfaction | Meta-analysis odds ratios for the two satisfaction outcomes (3.39, 95% CI 1.66–6.93; 2.32, 95% CI 1.75–3.08) both favored inflatable devices.[2] Individual three-piece series: 69.3%–87.7%.[1] | Individual malleable series: 69%–86.6%.[1] Inflatable devices are still the most commonly implanted type in the United States.[3] |
| Operative time | No pooled head-to-head figure was verified for this page. Editorial estimate used on this site: 60–90 minutes. | No pooled head-to-head figure was verified. Editorial estimate used on this site: 45–60 minutes. |
| Cost band (USD) | $15,000 – $25,000 | $8,000 – $15,000 |
| Insurance | Medicare policy states that treatment of impotence may be paid for and names penile prosthesis implantation as an example of surgical treatment.[7] Medicaid varies by state.[8] | Same Medicare language.[7] In one analysis, two states covered malleable devices only and one covered inflatable devices only.[8] |
Complication and survival ranges are taken from mostly retrospective series summarized in a narrative review; definitions of “failure,” “survival” and follow-up differ between series, so ranges are not directly comparable. Cost bands and operative-time estimates are editorial; no published national price or operative-time data were identified for a like-for-like comparison.
What the evidence does and does not show
Mechanical reliability. The clearest and most consistent finding is that the simpler device fails mechanically less often. A 2024 meta-analysis of five studies reported significantly more mechanical failure with inflatable prostheses, and a small single-center series of 131 men (93 malleable, 38 inflatable) found overall complication rates of 8.6% versus 21%, driven largely by mechanical failure of inflatable devices.[2, 4] A 2023 review likewise concluded that two semirigid rods carry a lower risk of malfunction and revision surgery than an inflatable device.[3] That is not the same as a failure rate of zero. The 2024 narrative review reports malleable dysfunction of up to 12% and survival of 83%–84% in long-term series, and it attributes the higher failure of inflatable devices to their greater complexity.[1]
Satisfaction. The same meta-analysis favored inflatable devices for both patient and partner satisfaction, which is consistent with the 2023 review’s statement that inflatable devices have higher patient satisfaction.[2, 3] Across individual series, however, reported satisfaction ranges overlap substantially (69%–87.7% for three-piece devices; 69%–86.6% for malleable devices), and the 2024 review notes that recent models of all three device types reach satisfaction of at least 75%.[1] Satisfaction is also shaped by expectations: perceived shortening is the most frequent complaint after any implant.[1]
Infection. The meta-analysis found no significant difference in infection between the two types, and the narrative review reached the same conclusion for the small series it examined.[1, 2] Published infection rates vary widely (from under 1% to several percent in primary implantation), which likely reflects differences in patient risk, device coating, technique and surgeon experience as well as device category. Infection is the complication most likely to require removal, so it deserves a direct question to the surgeon (see below).
Quality of the evidence. The meta-analysis authors noted that no earlier meta-analysis had compared the two designs, and it pooled only five studies.[2] No randomized head-to-head trial was identified. Treat every number on this page as an estimate with a wide margin of uncertainty.
Who should not choose each
An inflatable implant may be a poor fit if
- You cannot reliably locate and operate the scrotal pump. Poor manual dexterity is a recognized reason to prefer rods.[3]
- The retropubic space is scarred. Standard reservoir placement carries a higher risk after pelvic surgery or pelvic radiation, and robotic prostatectomy can disturb the space of Retzius; alternative (ectopic) reservoir placement exists but requires an experienced implanter.[1]
- You are being treated after device infection or prolonged priapism. Rods may be preferable as a salvage option after infection and after priapism lasting more than 48 hours, and can later be exchanged for an inflatable device.[3]
- Your priority is the lowest chance of a mechanical revision. This is where the evidence favors rods.[2, 3]
A malleable implant may be a poor fit if
- Concealment and a natural flaccid appearance matter most to you. A semi-rigid device is always firm and must be positioned; inflatable devices are rated better for concealability.[1, 5]
- Maximizing patient and partner satisfaction is the main goal. The pooled analysis favored inflatable devices.[2]
- You have significant Peyronie’s curvature. A European position statement rates inflatable devices superior for curvature correction, although a 2026 comparison of guidelines reports that the EAU guideline describes similar satisfaction with malleable devices, so professional views are not unanimous.[5, 6]
- You have reduced penile sensation. Erosion was reported more often with malleable devices in one review, so this is a specific point to raise with the surgeon.[1]
Neither may be appropriate if
Guideline summaries stress that an implant is irreversible and requires counseling.[9] A surgeon should confirm that less invasive options have been tried, declined or are unsuitable (see ED treatments compared: pills, shockwave, PRP and implants), and should discuss that perceived shortening is common after surgery.[1]
Choosing by circumstance
Hand function and dexterity
If you have tremor, weakness, loss of fine motor control or limited reach, ask for a hands-on trial of the pump during consultation. A malleable device removes the need for a pump entirely and is the usual recommendation when hand function is poor.[3]
Prior pelvic surgery or radiation
Prior pelvic surgery or radiation raises the risk of standard reservoir placement for three-piece devices, and ectopic reservoir placement is an established workaround.[1] In a small Turkish series, prior radical pelvic surgery and type 2 diabetes did not significantly change overall complication rates, but the numbers were small and subgroup counts were not reported in the abstract.[4] Ask your surgeon how often they place reservoirs ectopically and what their results are.
Peyronie’s disease
Men with Peyronie’s disease and erectile dysfunction that does not respond to medication are candidates for a prosthesis, with or without additional straightening maneuvers.[5, 6] A European position statement states that inflatable devices are superior for curvature correction, rigidity, girth and concealability,[5] while the guideline comparison reports the EAU describing similar satisfaction with malleable devices.[6] Two-piece inflatable devices are not recommended in Peyronie’s disease.[1] For the full decision framework, see Peyronie’s surgery: plication vs grafting vs implant and the Peyronie’s disease reconstruction page.
Budget and insurance
The editorial cost bands on this site are $15,000–$25,000 for a three-piece inflatable device and $8,000–$15,000 for a malleable device, covering surgeon, facility, anesthesia and device; no published national price data exist for a like-for-like comparison. Medicare’s national policy on impotence states that Medicare may pay for diagnosis and treatment and gives implantation of a penile prosthesis as an example of surgical treatment, but it does not set device-specific criteria.[7] A 2021 review of Medicaid fee schedules (49 states accessible) found that 24 states listed coverage for both device types, two for malleable only and one for inflatable only; 11 documented prior-authorization requirements, and the criteria were not clearly stated in any fee schedule.[8] The same analysis reported mean Medicaid physician reimbursement of $477.15 for malleable and $691.76 for inflatable implantation, which is a professional fee, not a total cost.[8] Request pre-authorization and a written estimate before scheduling, and ask whether a revision would be covered.
Partner preferences
Partner satisfaction was higher with inflatable devices in the pooled analysis.[2] Where the partner has strong views on appearance, firmness at rest or spontaneity, include them in the consultation. A device that is always firm and must be positioned is a daily consideration in a way that a deflating device is not.
Cost and recovery at a glance
| Item | Inflatable | Malleable |
|---|---|---|
| Editorial cost band | $15,000 – $25,000 | $8,000 – $15,000 |
| Return to work (site estimate) | 7 – 14 days | 5 – 10 days |
| Device activation / sexual activity | 4 – 6 weeks | 3 – 4 weeks |
Recovery estimates are editorial and match the procedure pages; individual timelines vary with surgeon protocol. See the penile implant recovery timeline and penile implant cost pages for detail.
Questions to ask your surgeon
- How many penile implants do you place each year, and how many are inflatable, malleable and revisions?
- Do you implant both types, and which would you recommend for me and why?
- What are your own infection and revision rates for each device, and over what follow-up?
- Which infection-prevention measures do you use (device coating, skin preparation, antibiotic protocol)?
- Given my pelvic surgery or radiation history, where would you place the reservoir, and how often have you done that?
- Can I handle the pump and, if relevant, the rod, in the office before deciding?
- What length and girth should I realistically expect, and how do you handle curvature if I have Peyronie’s disease?
- What will insurance and pre-authorization cover, and what happens financially if the device needs revision?
See how to choose a penile implant surgeon and our credential standard for what to verify: ABU board certification, SMSNA membership and andrology fellowship training.
Sources
- Patel J, Zakkar B, Polchert M, Tannenbaum J, Dick B, Raheem O. Recent technological development of penile prosthesis: a literature review. Transl Androl Urol. 2024;13(1):165–184. https://pmc.ncbi.nlm.nih.gov/articles/PMC10891389
- Satwikananda H, Laksita TB, Djatisoesanto W, Soebadi DM. Efficacy and safety of malleable penile prosthesis compared to inflatable penile prosthesis in erectile dysfunction patients (meta-analysis). Arch Ital Urol Androl. 2024;96(2). doi:10.4081/aiua.2024.12353. https://pagepressjournals.org/aiua/article/view/12353
- Khera M, Mulcahy J, Wen L, Wilson SK. Is there still a place for malleable penile implants in the United States? Wilson’s Workshop #18. Int J Impot Res. 2023;35(2):82–89. https://pubmed.ncbi.nlm.nih.gov/33273715/
- Kisa E, Keskin MZ, Yucel C, Ucar M, Yalbuzdag O, Ilbey YO. Comparison of penile prosthesis types’ complications: a retrospective analysis of single center. Arch Ital Urol Androl. 2020;92(4). doi:10.4081/aiua.2020.4.386. https://pubmed.ncbi.nlm.nih.gov/33348970/
- Osmonov D, Ragheb A, Ward S, et al. ESSM position statement on surgical treatment of Peyronie’s disease. Sex Med. 2022;10:100459. https://pmc.ncbi.nlm.nih.gov/articles/PMC8847818
- Chierigo F, Fallara G, Tozzi M, et al. Guideline of guidelines: Peyronie’s disease (comparison of the AUA 2015, ISSM 2016, CUA 2018 and EAU 2025 guidelines). BJU Int. 2026;137(5):770–782. https://pmc.ncbi.nlm.nih.gov/articles/PMC13071548
- Centers for Medicare & Medicaid Services. National Coverage Determination 230.4, Diagnosis and Treatment of Impotence (Medicare NCD Manual, Pub. 100-3). https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=32
- Barnard J, et al. Does Medicaid cover penile prosthesis surgery? A state-by-state analysis. J Sex Med. 2021. https://pubmed.ncbi.nlm.nih.gov/34247954/
- Gillman N, Chung E. Guideline of guidelines: a scoping review on comparison of major clinical guidelines for erectile dysfunction. Transl Androl Urol. 2026;15(7):254. https://pmc.ncbi.nlm.nih.gov/articles/PMC13458603
Cost figures are ranges and editorial estimates unless a source above states otherwise. This article is educational and is not medical advice.